Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 7/20 | 0.39 |
| ▸ | RAD52 | P43351 | 2/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.37 |
| ▸ | CDC25A | P30304 | 1/20 | 0.37 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.37 |
| ▸ | AKT1 | P31749 | 1/20 | 0.37 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
| ▸ | APAF1 | O14727 | 1/20 | 0.37 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.36 |
| ▸ | PRKCG | P05129 | 1/20 | 0.36 |
| ▸ | PRKCB | P05771 | 1/20 | 0.36 |
| ▸ | PRKCA | P17252 | 1/20 | 0.36 |
| ▸ | PRKCH | P24723 | 1/20 | 0.36 |
| ▸ | PRKCI | P41743 | 1/20 | 0.36 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6831358 | 0.91 | LPAR2 (0.44) | — | |
| SCHEMBL1906179 | 0.91 | LPAR2 (0.44) | — | |
| Hydrochloric Acid SCHEMBL7147494 | 0.89 | LPAR2 (0.42) | — | |
| Hydrochloric Acid SCHEMBL28430115 | 0.82 | DNM1 (0.38) | DNM1RAD52NPSR1LMNAESR1 | |
| SCHEMBL12257499 | 0.78 | LPAR3 (0.41) | HTTTHRBTSHRMEN1KMT2A | |
| SCHEMBL12257497 | 0.78 | LPAR3 (0.41) | HTTTHRBTSHRMEN1KMT2A | |
| SCHEMBL872445 | 0.78 | CES2 (0.35) | DNM1RAD52NPSR1LMNAESR1 | |
| SCHEMBL11508110 | 0.76 | THRB (0.38) | HTTTHRBTSHRMEN1KMT2A | |
| SCHEMBL15554489 | 0.76 | THRB (0.38) | HTTTHRBTSHRMEN1KMT2A | |
| SCHEMBL6021113 | 0.74 | MEN1 (0.45) | LMNAHTTTHRBTSHRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023196742-A9 | ANTI-CD90 ANTIBODIES, BINDING FRAGMENTS, AND USES THEREOF | FRED HUTCHINSON CANCER CENTER (US) | 2024-07-11 | — | — | WO | disclosed |
| WO-2023196742-A1 | ANTI-CD90 ANTIBODIES, BINDING FRAGMENTS, AND USES THEREOF | FRED HUTCHINSON CANCER CENTER (US) | 2023-10-12 | — | — | WO | disclosed |
| EP-3787996-A1 | NANOPARTICLES FOR GENE EXPRESSION AND USES THEREOF | Fred Hutchinson Cancer Research Center (US) | 2021-03-10 | — | — | EP | disclosed |
| EP-3740198-A1 | ALTERING INFLAMMATORY STATES OF IMMUNE CELLS IN VIVO BY MODULATING CELLULAR ACTIVATION STATES | Fred Hutchinson Cancer Research Center (US) | 2020-11-25 | — | — | EP | disclosed |
| WO-2020191060-A2 | CIRCUMSPOROZOITE PROTEINS WITH INCREASED EXPRESSION IN MAMMALIAN CELLS | FRED HUTCHINSON CANCER RESEARCH CENTER (US) | 2020-09-24 | — | — | WO | disclosed |
| EP-3565535-A1 | SYSTEMS AND METHODS TO IMPROVE VACCINE EFFICACY | Fred Hutchinson Cancer Research Center (US) | 2019-11-13 | — | — | EP | disclosed |
| WO-2019143948-A1 | ALTERING INFLAMMATORY STATES OF IMMUNE CELLS IN VIVO BY MODULATING CELLULAR ACTIVATION STATES | FRED HUTCHINSON CANCER RESEARCH CENTER (US) | 2019-07-25 | — | — | WO | disclosed |
| EP-3442585-A1 | COMPOSITIONS AND METHODS TO PROGRAM THERAPEUTIC CELLS USING TARGETED NUCLEIC ACID NANOCARRIERS | Fred Hutchinson Cancer Research Center (US) | 2019-02-20 | — | — | EP | disclosed |
| WO-2018129270-A1 | SYSTEMS AND METHODS TO IMPROVE VACCINE EFFICACY | FRED HUTCHINSON CANCER RESEARCH CENTER (US) | 2018-07-12 | — | — | WO | disclosed |
| WO-2017181110-A1 | COMPOSITIONS AND METHODS TO PROGRAM THERAPEUTIC CELLS USING TARGETED NUCLEIC ACID NANOCARRIERS | FRED HUTCHINSON CANCER RESEARCH CENTER (US) | 2017-10-19 | — | — | WO | disclosed |
| EP-2282724-A2 | MODIFIED DRUGS FOR USE IN LIPOSOMAL NANOPARTICLES | The University Of British Columbia (CA) | 2011-02-16 | — | — | EP | disclosed |
| WO-2009141738-A2 | MODIFIED DRUGS FOR USE IN LIPOSOMAL NANOPARTICLES | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2009-11-26 | — | — | WO | disclosed |